|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
127,470,000 |
Market
Cap: |
1.75(B) |
Last
Volume: |
679,143 |
Avg
Vol: |
1,075,670 |
52
Week Range: |
$11.665 - $20.73 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile NeoGenomics operate a network of cancer-focused testing laboratories in the U.S., Europe and Asia. Co.'s testing services include the following: Cytogenetics (karyotype analysis), a study of chromosomes and their relationship to disease; Fluorescence In-Situ Hybridization, a molecular cytogenetic technique that focuses on detecting and localizing the presence or absence of specific DNA sequences and genes on chromosomes; Flow cytometry, a technique utilized to measure the characteristics of cell populations; Immunohistochemistry and Digital Imaging; Molecular testing; and Morphologic analysis, a process of analyzing cells under the microscope.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
7,161 |
9,748 |
12,417 |
12,417 |
Total Sell Value |
$114,090 |
$152,803 |
$201,886 |
$201,886 |
Total People Sold |
2 |
2 |
2 |
2 |
Total Sell Transactions |
2 |
3 |
4 |
4 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Brown Douglas Matthew |
Chief Strategy Officer |
|
2021-11-26 |
4 |
AS |
$36.85 |
$1,228,358 |
D/D |
(33,334) |
11,644 |
|
-63% |
|
Bonello William |
President, Informatics |
|
2021-11-24 |
4 |
AS |
$37.13 |
$928,250 |
D/D |
(25,000) |
15,473 |
|
-63% |
|
Bonello William |
President, Informatics |
|
2021-11-24 |
4 |
OE |
$8.03 |
$200,750 |
D/D |
25,000 |
40,473 |
|
- |
|
Brown Douglas Matthew |
Chief Strategy Officer |
|
2021-11-24 |
4 |
AS |
$36.84 |
$1,227,988 |
D/D |
(33,333) |
44,978 |
|
-63% |
|
Brown Douglas Matthew |
Chief Strategy Officer |
|
2021-11-23 |
4 |
AS |
$37.19 |
$1,239,654 |
D/D |
(33,333) |
78,311 |
|
-69% |
|
Daly David |
Director |
|
2021-11-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,623 |
1,623 |
|
- |
|
Tetrault Lynn A. |
Director |
|
2021-10-11 |
4 |
A |
$0.00 |
$0 |
D/D |
838 |
35,777 |
|
- |
|
Gilbert Halley E |
Chief Legal Officer |
|
2021-08-17 |
4 |
A |
$0.00 |
$0 |
D/D |
59,228 |
59,228 |
|
- |
|
Van Oort Douglas M |
Director |
|
2021-08-01 |
4 |
D |
$46.10 |
$272,866 |
D/D |
(5,919) |
2,468,797 |
|
- |
|
Balliet Jennifer |
VP and Chief Culture Officer |
|
2021-07-05 |
4 |
A |
$0.00 |
$0 |
D/D |
758 |
27,215 |
|
- |
|
Cardoza George |
President & COO, Lab Ops |
|
2021-07-05 |
4 |
A |
$0.00 |
$0 |
D/D |
7,584 |
184,356 |
|
- |
|
Wallar Gina M |
President, Pharma Services |
|
2021-07-05 |
4 |
A |
$0.00 |
$0 |
D/D |
1,896 |
6,013 |
|
- |
|
Dieter Cynthia J |
Chief Accounting Officer |
|
2021-06-22 |
4 |
D |
$43.99 |
$2,463 |
D/D |
(56) |
1,790 |
|
- |
|
Morris Clive |
President of Inivata |
|
2021-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
10,708 |
10,708 |
|
- |
|
Tetrault Lynn A. |
Director |
|
2021-06-11 |
4 |
OE |
$9.11 |
$12,654 |
D/D |
1,389 |
34,939 |
|
- |
|
Crowther Bruce K |
Director |
|
2021-06-08 |
4 |
S |
$41.46 |
$859,632 |
D/D |
(20,734) |
49,564 |
|
-4% |
|
Crowther Bruce K |
Director |
|
2021-06-08 |
4 |
OE |
$7.27 |
$302,241 |
D/D |
20,734 |
70,298 |
|
- |
|
Cardoza George |
President, Pharma Services |
|
2021-06-03 |
4 |
S |
$40.11 |
$1,247,702 |
D/D |
(31,107) |
176,772 |
|
-2% |
|
Cardoza George |
President, Pharma Services |
|
2021-06-02 |
4 |
S |
$40.39 |
$6,835,200 |
D/D |
(169,230) |
207,879 |
|
-4% |
|
Crowther Bruce K |
Director |
|
2021-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,081 |
49,564 |
|
- |
|
Stahler Rachel A |
Director |
|
2021-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,081 |
5,779 |
|
- |
|
Tetrault Lynn A. |
Director |
|
2021-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,081 |
33,550 |
|
- |
|
Kelly Michael Aaron |
Director |
|
2021-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,081 |
4,863 |
|
- |
|
Hannah Alison L. |
Director |
|
2021-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,081 |
91,877 |
|
- |
|
Kanovsky Stephen M |
Director |
|
2021-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,081 |
9,198 |
|
- |
|
544 Records found
|
|
Page 4 of 22 |
|
|